Computer Vision Syndrome Visual Sequelae

NCT ID: NCT04398212

Last Updated: 2020-08-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

733 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-05-21

Study Completion Date

2020-08-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

the university students will respond to CVS-F3 survey form and then they will be subjected to complete ophthalmic examination and investigations

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

CVS-F3 is a survey form consisted of up to 30 questions regarding Computer Vision Syndrome (CVS) complains, thereafter a randomized sample of students will be subjected to complete ophthalmic examination including visual acuity and refractive measurements, intraocular pressure measurements, Slitlamp and fungus examinations, mfERG examinations. the sudents will be requested to decrease their screen time and the examinations will be repeated one month later.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Computer Vision Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

SINGLE

Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Non-complaining group

the students in this group are not complaining of CVS symptoms but will be examined to diagnose CVS or exclude it

Group Type PLACEBO_COMPARATOR

mfERG (multifocal-retinogram)

Intervention Type DIAGNOSTIC_TEST

mfERG will be performed for the students to document the effect of CVS on retina

Complaining group

the students in this group are complaining of CVS symptoms but will be examined to document their complains and correlate to clinical findings

Group Type EXPERIMENTAL

mfERG (multifocal-retinogram)

Intervention Type DIAGNOSTIC_TEST

mfERG will be performed for the students to document the effect of CVS on retina

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

mfERG (multifocal-retinogram)

mfERG will be performed for the students to document the effect of CVS on retina

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

\- University students

Exclusion Criteria

* Amblyopia
* Anisometropia
* strabismus
* Previous eye surgery
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Sohag University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Prof. Mohammed Iqbal

Assistant Professor of Ophthalmology

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mohammed Iqbal, MD. PhP

Role: PRINCIPAL_INVESTIGATOR

Sohag University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Faculty of medicine

Sohag, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

5-10/4/2018

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Mitomycin-c Application for PRK
NCT01504282 COMPLETED NA